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The MDAR (Materials Design Analysis Reporting)
Framework for transparent reporting in the
life sciences
Malcolm Macleoda,1, Andrew M. Collingsb, Chris Grafc, Veronique Kiermerd, David Mellore,1,
Sowmya Swaminathanf, Deborah Sweetg, and Valda Vinsonh
Transparency in reporting benefits scientific communi-
cation on many levels. While specific needs and expec-
tations vary across fields, the effective interpretation and
use of research findings relies on the availability of core
information about research materials, study design,
data, and experimental and analytical methods. For pre-
clinical research, transparency in reporting is a key focus
in response to concerns of replication failure. The incon-
sistent reporting of key elements of experimental and
analytical design, alongside ambiguous description of
reagents and lack of access to underlying data and code,
has been shown to impair replication (1) and raise doubt
about the robustness of results (2, 3). In response to early
concerns about replication of published results, funders,
publishers, and other stakeholders have called for im-
provements in reporting transparency (4–7). Several ini-
tiatives ensued, including journal policies and joint
efforts by journals, funders, and other stakeholders
(8–10). One of these initiatives, the Transparency and
Openness Promotion (TOP) guidelines (11), outlines a
policy framework at the journal level that over 1,000 jour-
nals and publishers have adopted.
The National Academies have focused on repro-
ducibility and replicability* challenges through several
recent initiatives leading to consensus reports, includ-
ing Reproducibility and Replicability in Science (12),
Open Science by Design: Realizing a Vision for 21st
Century Research (13), and Fostering Integrity in Re-
search (14). Each of these reports concludes that lack
of reporting transparency is one factor which contrib-
utes to these systemic problems. Building on these
findings, the National Academies convened a public
workshop in September 2019 titled “Enhancing Scien-
tific Reproducibility in Biomedical Research Through
Transparent Reporting.” The workshop was designed
to discuss the current state of transparency in reporting
biomedical research and to explore the possibility of
improving the harmonization of guidelines across jour-
nals and funding agencies.
During this workshop, we provided a preliminary
description of our MDAR initiative, the Materials Design
Analysis Reporting Framework (15). Our MDAR working
group came together in late 2017 with the intention to
develop a policy framework to promote transparent
reporting that would support article-level application of
the principles of the TOP guidelines, with a focus on
implementation through journal policies and editorial
practice. Our goal was to develop a framework and an
implementation support system that would be practi-
cally applicable for a broad range of journals in the life
sciences. In many ways, the MDAR Framework is a joint
iteration on our collective previous experience with
guidelines, checklists, and editorial requirements, to-
ward a harmonized and practical guideline for minimum
reporting requirements.
The National Academies of Science, Engineering,
and Medicine (NASEM) workshop provided a valuable
opportunity for broader consultation across relevant
stakeholder groups (16). We incorporated the feed-
back we received at the workshop, and here we report
the results of our project in the form of three main
MDAR outputs: the MDAR Framework, which forms
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the core policy recommendation, and the Checklist and
Elaboration documents, which support its implementation
(Box 1). We present these outputs as a contribution to
help life sciences journals achieve the opportunities
highlighted during the NASEM workshop through a
pragmatic and harmonized approach.
Devising a Harmonized Reporting Framework
In devising this Framework, we drew not only on the
collective experience of journal initiatives, including
existing checklists, but also on the results of recent
meta-research studying the efficacy of such interven-
tions (17–19), existing transparency and reporting
frameworks (20, 21), and the above-mentioned
NASEM consensus reports (see SI Appendix—MDAR
Elaboration for a complete list of baseline reference
material). We had a strong focus on straightforward
and pragmatic approaches to implementation and
on balancing the demands of research users for im-
proved reporting with reasonable expectations for
authors, reviewers, and editors. Therefore, we have
not attempted to make the Framework comprehen-
sive, but we have consulted broadly to include the
elements that, considering current practice, could
bring the most notable improvements across a large
number of journals.
The scope of the MDAR Framework was the life
sciences, and within this our project had a strong focus
on information that is relevant for exploratory labora-
tory research; MDAR is therefore likely to be more
useful for some disciplines than for others. We also
recognize the added value of many community-
endorsed specialized guidelines that go further in
their more focused expectations of more specific re-
search areas. The MDAR Framework is not compre-
hensive and should not supersede any existing
reporting standards. It is a generalist framework
intended to be broadly applicable to research in the
life sciences and to lift minimum expectations in a
concerted way. MDAR is meant to be not only com-
patible with but also to be enhanced by existing
specialist standards and guidelines (e.g., EQUATOR
Network, FAIRsharing, and ARRIVE).
The organizing principles of the MDAR Framework
centered around three types of information: accessi-
bility, identification, and characterization. Accessibility
refers to the disclosure of whether and how a specific
Framework element (e.g., material, data, code, or
protocols) is accessible, including any restrictions to
that access. Identification refers to the information
necessary for unique and unambiguous designation
and provenance of each element (typically this in-
cludes a unique persistent identifier). Characterization
refers to the minimum description of the item which is
relevant for interpretation and replication.
For each element of the Framework, we have
identified a basic minimum requirement as well as an
aspirational set of best practices that provide directional
guidance for the future evolution of the requirements.
With time we expect that elements currently identified as
“best practice” will instead be identified as a “basic min-
imum requirement” as reporting performance improves.
A Road Test and Broad Consultation
New approaches to improving reproducibility and
replicability bring with them costs of adoption and
implementation. If the costs to journals outweigh the
benefits they will stop using the MDAR Framework,
but it is more difficult to account for the additional
burden placed on authors. Authors do recognize that
checklists can improve reporting quality (22), and this
is supported, to an extent, by empirical research (17–
19); a strategy of using simple checklists which incur
the lowest burden is reasonable. Ultimately, improved
reproducibility and replicability benefits future re-
searchers as they attempt to build on previous work,
so there is also broader value from such endeavors.
Previous experience highlighted the benefits not
only of broad stakeholder consultation but also of
testing interventions in “real-life” situations before
implementation. We therefore reached out to the
publishing community to recruit volunteer journals for
a pilot study. Thirteen journals and publishing plat-
forms participated: BMC Microbiology and Ecology
and Evolution, eLife, EMBO journals, Epigenetics,
F1000R, Molecular Cancer Therapeutics, Micro-
biologyOpen, PeerJ, PLOS Biology, PNAS, Science,
and Scientific Reports. As a proxy for testing the
MDAR Framework, we tested its main implementation
tool, the MDAR Checklist, a series of questions
designed to determine whether a study adheres to the
minimum requirements in the MDAR Framework. The
participants were also given the MDAR Elaboration
Document as a further guide to clarify expectations.
Box 1. Description of MDAR outputs
MDAR output Description of MDAR output
MDAR Framework The Framework sets out minimum requirements and best-practice recommendations across four
core areas of Materials (including data and code), Design, Analysis, Reporting (MDAR). https://
osf.io/xfpn4/
MDAR Checklist The checklist is intended as an optional tool to help operationalize the Framework by serving as an
implementation tool to aid authors complying with journal policies and editors and reviewers in
assessing reporting and adherence to the standard. https://osf.io/bj3mu/
MDAR Elaboration
document
The Elaboration document is a user guide providing context for the MDAR Framework and
Checklist and recommendations on how to use them and tracking the MDAR development
process and rationale. https://osf.io/xzy4s/
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The pilot sought, first, to understand whether the
MDAR Checklist described each reporting standard
with sufficient clarity to guide the assessment of sub-
mitted manuscripts and, second, whether the Check-
list was useful to authors seeking to meet journal
policy expectations and to editors assessing manu-
scripts against those requirements.
Participating journal teams screened 289 manu-
scripts using the checklist; 89 of these were assessed
twice, by independent journal assessors blinded to
each other’s assessment, to determine interassessor
agreement. We interpreted poor (no better than
expected by chance) interobserver agreement as an
indication of insufficient clarity and revisited the de-
scription of affected items in the Checklist and Elab-
oration document to clarify them. Specifically, there
had been poor agreement around the provenance of
cell lines, primary cultures, and microbes, in details of
ethical approvals, and on whether criteria for exclusion
had been determined prior to data collection. We
suggest that implementing journals may wish to give
particular attention to these items in the training of
editorial staff. Only 15 of 42 items were considered
relevant to more than half of the 289 manuscripts
considered. To address this, a common suggestion
from study participants was to organize the checklist in
a nested way to allow users to easily skip over sections
that are not relevant. While this is an excellent sug-
gestion, we concluded that the best organization may
be journal-specific and left this as an implementation
decision for the journals electing to use a checklist.
Across all participating journals we sought feed-
back from a corresponding author of these 289 man-
uscripts (some manuscripts had more than one
corresponding author), and from editorial staff mem-
bers handing those manuscripts. Eighty percent of
211 corresponding authors who responded, and 84%
of 33 editorial staff, found the checklist “very” or
“somewhat” helpful.
We also obtained further feedback on the MDAR
Framework, Elaboration document, and Checklist
from 42 experts with experience in various aspects of
reproducibility and replicability, including using and
developing checklists to improve reporting standards.
While incorporating this feedback and refining the
Framework and associated outputs further we added
and strengthened some requirements but we were
careful to ensure that the minimum requirements
remained reasonable and pragmatic to avoid undue
burden on authors, given current practice.
Endorsing and Adopting the MDAR Framework
We developed the MDAR Framework as an adaptable
system allowing flexible adoption to meet the differ-
ent needs of specific disciplines, community norms,
and resource constraints. We envision that by en-
dorsing the MDAR Framework journal signatories will
express their support for transparent reporting prin-
ciples outlined by the MDAR Framework and commit
to taking steps to incorporate the MDAR guidelines
into their journal practices.
Having endorsed the MDAR Framework, journals
can choose from three increasingly stringent levels of
implementation to give signatories flexibility, allowing
a lower threshold for entry but nevertheless providing
a clear path to improving standards (Box 2).
The MDAR Checklist is available as an optional
resource, or tool, to help drive implementation of the
Framework, but the Framework itself is purposely
designed to be compatible with other modes of
implementation including through structured queries
in journal peer-review systems, integration within
Box 2. Implementing MDAR at three tiers of stringency
MDAR implementation tiers Example policy statement on journal/publisher policy sites
Recommend: “XX endorse the Materials Design Analysis Reporting (MDAR)
Framework for minimum reporting standards in the life
sciences and encourage authors to consider all aspects of
MDAR Framework (provide link to MDAR materials) relevant
to study when submitting the study. Authors may submit the
MDAR Checklist with their manuscripts.”
*Endorses MDAR Framework and recommends authors
consider aspects of MDAR Framework relevant to study
when submitting study.
*MDAR Framework not mandatory and not enforced.
*May encourage use of MDAR checklist
Limited mandate: “XX endorse the Materials Design Analysis Reporting (MDAR)
Framework for minimum reporting standards in the life
sciences and encourages authors to consider all aspects of
MDAR Framework (provide link to MDAR materials) relevant
to study when submitting the study. We require all studies
using cell lines to adhere to the minimum reporting
standards described in the MDAR framework. Authors may
submit the MDAR Checklist with their manuscripts.”
*Endorses MDAR Framework and recommends authors
consider aspects of MDAR Framework relevant to study
when submitting study.
*Additionally, commits to require limited aspects of MDAR
Framework (see example with reference to cell lines)
*May encourage use of MDAR checklist
Full mandate: “XX endorse the Materials Design Analysis Reporting (MDAR)
Framework for minimum reporting standards in the life
sciences. We require that reporting in life science papers
adhere to all aspects of the minimum reporting standards
set out in the MDAR Framework. Authors are encouraged/
required to submit the MDAR Checklist with their
manuscripts.”
*Endorses MDAR Framework.
*Commits to require compliance on all aspects of MDAR
Framework
*May encourage or require use of MDAR checklist
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journal-specific guidelines or checklists, or automated
or semiautomated manuscript processing systems.
Some journals already have policies that go be-
yond the minimum set of requirements and are
aligned with the aspirational best practices described
in the MDAR Framework. We expect that these jour-
nals will continue to implement their best practices
while endorsing the Framework. Their experience will
be central to inform future evolution of the minimum
set of requirements in the MDAR Framework.
Some journals may wish to endorse the MDAR
Framework but may be concerned about the burden on
editorial resources. It is important to note that during the
pilot in which editorial staff used the checklist to evaluate
MDAR compliance the average time was 24 min (median
15 min). The assessment was largely carried out by in-
ternal journal staff and we did not test the checklist with
volunteer reviewers or editors. However, as outlined in
Box 2, the MDAR Framework can be recommended or
required without the use of the checklist. One option
could be that authors are asked to complete a checklist as
part of their submission, with this being published as a
supplement without monitoring compliance. This would
raise awareness about reporting expectations, increase
accountability for authors, and provide added value for
readers but would require fewer editorial resources
for implementation.
What Comes Next?
The Center for Open Science (COS), which has been a
partner in developing the MDAR Framework, will be
responsible for stewardship, as a community resource,
of the MDAR Framework and associated outputs in-
cluding the Elaboration document and Checklist. COS
will maintain a webpage to curate the checklist, Elabo-
ration document, and any policy recommendations.
These will be housed in a repository on the Metascience
Collection on the Open Science Framework, which is
developed and maintained by COS. The Metascience
Collection contains data,materials, and research outputs
relevant to the scientific community and enables re-
sources such as the MDAR outputs to be maintained in
version-controlled documents with persistent, unique
identifiers. We hope to see widespread adoption of the
MDAR Framework, and we ask journals and platforms to
share details on this platform when they start to use the
MDAR Framework.
Alignment around MDAR as a common standard
for life-science papers will hopefully pave the way for
the development of automated—and semiautomated—
assessment tools that can determine manuscript ad-
herence to reporting standards, potentially reducing
barriers to wider uptake of the Framework (23). As the
MDAR Framework is likely to evolve, we strongly
encourage interested developers to focus not only
on the minimum requirements but also on the aspi-
rational best practices outlined in the Framework.
While journals are a key target audience, the MDAR
Framework could be used by multiple stakeholders at
different points in the research life cycle: by researchers
during the design, conduct, analysis, and reporting of
research studies; by institutions as a pedagogical tool to
teach best practice in responsible conduct of research;
and by funders and others involved in research assess-
ment to help evaluate rigor and reporting transparency
in grant applications, preprints, or research articles. With
the growth in preprints in recent years, preprint servers
are uniquely placed to collect (and post) an author-
completedMDAR checklist, which could then travel with
the manuscript when submitted to a journal. In all
implementations it will be desirable to make the process
of engagement with the MDAR Framework as straight-
forward for authors as possible.
Improved consistency in expectations for reporting
across publishers has the potential to ease adoption of
transparent reporting practices for authors, researchers,
and journals and lead to improved quality of reporting
in published papers. In addition, alignment on these
expectations among funders could further help drive
adoption and incorporation of best-practice recom-
mendations early, into study design, data collection, and
analysis. Ultimately the goal of transparent reporting is to
improve research practice.
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